174 related articles for article (PubMed ID: 36017064)
1. Omalizumab is effective in nasal polyposis with or without asthma, a real-life study.
Tat TS
World Allergy Organ J; 2022 Aug; 15(8):100670. PubMed ID: 36017064
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials.
Gevaert P; Omachi TA; Corren J; Mullol J; Han J; Lee SE; Kaufman D; Ligueros-Saylan M; Howard M; Zhu R; Owen R; Wong K; Islam L; Bachert C
J Allergy Clin Immunol; 2020 Sep; 146(3):595-605. PubMed ID: 32524991
[TBL] [Abstract][Full Text] [Related]
3. Effects of Omalizumab Treatment in Patients With Recalcitrant Nasal Polyposis and Mild Asthma: A Multicenter Retrospective Study.
Armengot-Carceller M; Gómez-Gómez MJ; García-Navalón C; Doménech-Campos E; Muñoz-Fernández N; Miguel AG; Marco-Algarra J; Palop-Cervera M; Piñero AG
Am J Rhinol Allergy; 2021 Jul; 35(4):516-524. PubMed ID: 33153272
[TBL] [Abstract][Full Text] [Related]
4. The Effectiveness of Biological Agents on Chronic Rhinosinusitis with Nasal Polyposis in Patients with Comorbid Asthma: A Multicenter Real-Life Study from Türkiye.
Demir M; Tunakan Dalgic C; Mete Gokmen EN; Savas R; Eroglu S; Ozden G; Orcen C; Pacaci Cetin G; Arslan B; Bilgir F; Bulut G; Akcam NY; Ozgul S; Cerci P; Coskun R; Gode S; Yilmaz I; Sin AZ
Medicina (Kaunas); 2024 Mar; 60(3):. PubMed ID: 38541174
[No Abstract] [Full Text] [Related]
5. Omalizumab improves sinonasal outcomes in patients with chronic rhinosinusitis with nasal polyps regardless of allergic status.
Gevaert P; Mullol J; Saenz R; Ko J; Steinke JW; Millette LA; Meltzer EO
Ann Allergy Asthma Immunol; 2024 Mar; 132(3):355-362.e1. PubMed ID: 37951571
[TBL] [Abstract][Full Text] [Related]
6. Clinical effectiveness and potential predictability of omalizumab in patients with difficult-to-treat chronic rhinosinusitis with nasal polyps and asthma based on the noninvasive markers - A real-life prospective study.
Zheng M; Sima Y; Liu C; Zhao J; Shao S; Wang X; Wang Y; Cao F; Xiong W; Wang X; Zhang L
World Allergy Organ J; 2022 Oct; 15(10):100702. PubMed ID: 36254182
[TBL] [Abstract][Full Text] [Related]
7. [A real world study of anti-IgE monoclonal antibody in the treatment of allergic united airway disease].
Sui HJ; Zhen Z; Wang QG; Cong TC; Huang JJ; Hu Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Feb; 57(2):273-280. PubMed ID: 36797588
[No Abstract] [Full Text] [Related]
8. Defining the Efficacy of Omalizumab in Nasal Polyposis: A POLYP 1 and POLYP 2 Subgroup Analysis.
Damask C; Chen M; Holweg CTJ; Yoo B; Millette LA; Franzese C
Am J Rhinol Allergy; 2022 Jan; 36(1):135-141. PubMed ID: 34382434
[TBL] [Abstract][Full Text] [Related]
9. [Short-term efficacy of anti-IgE monoclonal antibody in patients with recurrent chronic rhinosinusitis with nasal polyps combined with asthma].
Shen S; Lou HF; Yan B; Wang Y; Cao FF; Xiong W; Wang CS; Zhang L
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Oct; 56(10):1035-1041. PubMed ID: 34666463
[No Abstract] [Full Text] [Related]
10. Real-Life Effects of Omalizumab on Chronic Rhinosinusitis with Nasal Polyposis.
Lombardo N; Piazzetta GL; Lobello N; Cicala G; Patafi M; Benincasa AT; Pelaia C; Chiarella E; Pelaia G
J Pers Med; 2023 Dec; 14(1):. PubMed ID: 38276218
[TBL] [Abstract][Full Text] [Related]
11. Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study.
Gevaert P; Saenz R; Corren J; Han JK; Mullol J; Lee SE; Ow RA; Zhao R; Howard M; Wong K; Islam L; Ligueros-Saylan M; Omachi TA; Bachert C
J Allergy Clin Immunol; 2022 Mar; 149(3):957-965.e3. PubMed ID: 34530020
[TBL] [Abstract][Full Text] [Related]
12. Omalizumab Treatment in Uncontrolled Asthma and CRSwNP Patients, with Previous Endoscopic Sinus Surgery, to Improve Quality of Life and Endoscopic Outcomes: a Two-Year Real-Life Study.
Maza-Solano J; Callejon-Leblic A; Martin-Jimenez D; Moreno-Luna R; Gonzalez-Garcia J; Cuvillo A; Sanchez-Gomez S
Curr Allergy Asthma Rep; 2023 Oct; 23(10):555-566. PubMed ID: 37644255
[TBL] [Abstract][Full Text] [Related]
13. A real-life comparison of pulmonary and nasal outcomes in patients with severe asthma and nasal polyposis treated with T2-biologics.
Förster-Ruhrmann U; Stergioudi D; Szczepek AJ; Fluhr JW; Zuberbier T; Olze H; Bergmann KC
World Allergy Organ J; 2023 Feb; 16(2):100746. PubMed ID: 36852411
[TBL] [Abstract][Full Text] [Related]
14. Omalizumab treats chronic rhinosinusitis with nasal polyps and asthma together-a real life study.
Bidder T; Sahota J; Rennie C; Lund VJ; Robinson DS; Kariyawasam HH
Rhinology; 2018 Mar; 56(1):42-45. PubMed ID: 29288573
[TBL] [Abstract][Full Text] [Related]
15. Revision surgery versus biologic treatment with omalizumab in recurrent chronic rhinosinusitis with nasal polyps: An analysis of cost-utility and clinical outcomes.
Sima Y; Zhang J; Zheng M; Zhao Y; Wang X; Zhang L
World Allergy Organ J; 2023 Dec; 16(12):100846. PubMed ID: 38090211
[TBL] [Abstract][Full Text] [Related]
16. State-of-the-art overview on biological treatment for CRSwNP.
Hellings PW; Verhoeven E; Fokkens WJ
Rhinology; 2021 Apr; 59(2):151-163. PubMed ID: 33459728
[TBL] [Abstract][Full Text] [Related]
17. Biologic Therapies for Allergic Rhinitis and Nasal Polyposis.
Geng B; Dilley M; Anterasian C
Curr Allergy Asthma Rep; 2021 Jun; 21(6):36. PubMed ID: 34110505
[TBL] [Abstract][Full Text] [Related]
18. Anti-IgE and Anti-IL5 Biologic Therapy in the Treatment of Nasal Polyposis: A Systematic Review and Meta-analysis.
Rivero A; Liang J
Ann Otol Rhinol Laryngol; 2017 Nov; 126(11):739-747. PubMed ID: 28918644
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of omalizumab in patients with severe allergic asthma with and without chronic rhinosinusitis with nasal polyps: a PROXIMA study post hoc analysis.
Heffler E; Saccheri F; Bartezaghi M; Canonica GW
Clin Transl Allergy; 2020; 10():25. PubMed ID: 32607141
[TBL] [Abstract][Full Text] [Related]
20. The role of omalizumab in the treatment of chronic rhinosinusitis with nasal polyposis.
Aldinger JP; Dobyns T; Lam K; Han JK
Expert Opin Biol Ther; 2021 Sep; 21(9):1143-1149. PubMed ID: 34334061
[No Abstract] [Full Text] [Related]
[Next] [New Search]